• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Drug Policy

    Tag: Drug Policy

    The main activities that drug makers get penalized for are illegally marketing a drug to a doctor, and deliberately overcharging Medicare or Medicaid.
    Healthcare

    Patent Office is asking the right questions to lower drug costs

    Dr. Rachel Goode -
    January 6, 2023 11:00 am
    0
    Median price of newly approved drugs topped $200,000 last year, analysis finds
    News

    Median price of newly approved drugs topped $200,000 last year, analysis finds

    Abigail Adcox -
    January 5, 2023 6:48 pm
    0
    FDA set to make decision on experimental Alzheimer’s drug this week
    News

    FDA set to make decision on experimental Alzheimer’s drug this week

    Abigail Adcox -
    January 3, 2023 8:05 pm
    0
    FILE - An AmerisourceBergen Corp. office building stands on Oct. 16, 2019, in Conshohocken, Pa.

    Drug distributor AmerisourceBergen sued by federal government over role in opioid crisis

    Brady Knox -
    December 30, 2022 1:40 am
    0
    Rep. Chip Roy (R-TX) grilled the U.S. Attorney General about the DOJ's handling of the parental rights movement.
    News

    WATCH: Magic mushrooms on ballot for voters in Colorado

    Julia Johnson -
    November 2, 2022 9:39 pm
    0
    In this May 10, 2018 photo, a Narcan nasal spray dispenser is displayed in New York.
    News

    Narcan to be supplied at LA school district after recent overdoses

    Brady Knox -
    September 23, 2022 3:38 am
    0
    Republicans push harsher penalties for fentanyl dealing — including death
    News

    Republicans push harsher penalties for fentanyl dealing — including death

    Abigail Adcox -
    September 21, 2022 12:00 am
    0
    Democrats play dangerous game with FDA reauthorization
    News

    Democrats play dangerous game with FDA reauthorization

    Sally Pipes -
    September 20, 2022 12:00 am
    0
    U.S. deterrence policy has generated plenty of criticism from Capitol Hill. But that has been aimed at the administration's supposedly narrow view of what constitutes an attack and unwillingness to spell out likely responses.
    Fairness and Justice

    Marijuana black markets flourish despite legalization

    Abigail Adcox -
    September 15, 2022 11:00 pm
    0
    Sen. Joe Manchin (D-WV), left, walks with Sen. Kyrsten Sinema (D-AZ) on Nov. 16, 2021, on Capitol Hill in Washington. Sinema agreed to sign onto new Democratic legislation that would impose a 1% excise tax on stock buybacks.
    Healthcare

    Bitter pill to swallow: Manchin and Sinema split over prescription drug prices

    Misty Severi -
    August 20, 2022 12:44 am
    0
    1...101112...21Page 11 of 21
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.